Cargando…

Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses

BACKGROUND: Despite the fact that metastases are the leading cause of colorectal cancer deaths, little is known about the underlying molecular changes in these advanced disease stages. Few have studied the overall gene expression levels in metastases from colorectal carcinomas, and so far, none has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kleivi, Kristine, Lind, Guro E, Diep, Chieu B, Meling, Gunn I, Brandal, Lin T, Nesland, Jahn M, Myklebost, Ola, Rognum, Torleiv O, Giercksky, Karl-Erik, Skotheim, Rolf I, Lothe, Ragnhild A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1770935/ https://www.ncbi.nlm.nih.gov/pubmed/17201907 http://dx.doi.org/10.1186/1476-4598-6-2

Ejemplares similares

Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients
por: Diep, Chieu B, et al.
Publicado: (2004)

ADAMTS1, CRABP1, and NR3C1 Identified as Epigenetically Deregulated Genes in Colorectal Tumorigenesis
por: Lind, Guro E., et al.
Publicado: (2006)

Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers
por: Ahlquist, Terje, et al.
Publicado: (2008)

A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines
por: Lind, Guro E, et al.
Publicado: (2004)

Hypermethylated MAL gene – a silent marker of early colon tumorigenesis
por: Lind, Guro E, et al.
Publicado: (2008)

Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas
por: Lind, Guro E, et al.
Publicado: (2011)

Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival
por: Sveen, Anita, et al.
Publicado: (2011)

The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer
por: Vedeld, Hege Marie, et al.
Publicado: (2014)

MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer
por: Cekaite, Lina, et al.
Publicado: (2015)

Novel Genomic Aberrations in Testicular Germ Cell Tumors by Array-CGH, and Associated Gene Expression Changes
por: Skotheim, Rolf I., et al.
Publicado: (2006)

Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis
por: Løvig, T, et al.
Publicado: (2002)

A Tissue-Based Comparative Effectiveness Analysis of Biomarkers for Early Detection of Colorectal Tumors
por: Ahmed, Deeqa, et al.
Publicado: (2012)

DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets
por: Wu, Qinghua, et al.
Publicado: (2007)

Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies
por: Berg, Kaja C. G., et al.
Publicado: (2017)

Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment
por: Jeanmougin, Marine, et al.
Publicado: (2020)

The loss of NKX3.1 expression in testicular – and prostate – cancers is not caused by promoter hypermethylation
por: Lind, Guro E, et al.
Publicado: (2005)

Phospholipase C Isozymes Are Deregulated in Colorectal Cancer – Insights Gained from Gene Set Enrichment Analysis of the Transcriptome
por: Danielsen, Stine A., et al.
Publicado: (2011)

MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
por: Håvik, Annette Bentsen, et al.
Publicado: (2012)

Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1
por: Sveen, Anita, et al.
Publicado: (2017)

“Hirnsymptome bei Carcinomatose” — Hermann Oppenheim and an Early Description of a Paraneoplastic Neurological Syndrome
por: Schulz, Paulina, et al.
Publicado: (2015)

High Frequency of Fusion Transcripts Involving TCF7L2 in Colorectal Cancer: Novel Fusion Partner and Splice Variants
por: Nome, Torfinn, et al.
Publicado: (2014)

Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours – A prognostic test after surgical resection
por: Kolberg, Matthias, et al.
Publicado: (2015)

A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis
por: Skotheim, Rolf I, et al.
Publicado: (2009)

Transcriptome instability as a molecular pan-cancer characteristic of carcinomas
por: Sveen, Anita, et al.
Publicado: (2014)

Cysteine-Rich Secretory Protein-3 (CRISP3) Is Strongly Up-Regulated in Prostate Carcinomas with the TMPRSS2-ERG Fusion Gene
por: Ribeiro, Franclim R., et al.
Publicado: (2011)

Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer
por: Vedeld, Hege Marie, et al.
Publicado: (2018)

Prognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series
por: Bruun, Jarle, et al.
Publicado: (2014)

High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity
por: Kidd, Susanne G., et al.
Publicado: (2021)

Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis.
por: Meling, G. I., et al.
Publicado: (1991)

The TP53 tumour suppressor gene in colorectal carcinomas. II. Relation to DNA ploidy pattern and clinicopathological variables.
por: Meling, G. I., et al.
Publicado: (1993)

The TP53 tumour suppressor gene in colorectal carcinomas. I. Genetic alterations on chromosome 17.
por: Meling, G. I., et al.
Publicado: (1993)

Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer
por: Eilertsen, Ina A., et al.
Publicado: (2018)

The expressed mutational landscape of microsatellite stable colorectal cancers
por: Sveen, Anita, et al.
Publicado: (2021)

Spindle proteins are differentially expressed in the various histological subtypes of testicular germ cell tumors
por: Burum-Auensen, Espen, et al.
Publicado: (2010)

Assessment of Fusion Gene Status in Sarcomas Using a Custom Made Fusion Gene Microarray
por: Løvf, Marthe, et al.
Publicado: (2013)

Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts
por: Mesquita, Diana, et al.
Publicado: (2015)

MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines
por: Ohnstad, Hege O, et al.
Publicado: (2011)

Interfocal heterogeneity challenges the clinical usefulness of molecular classification of primary prostate cancer
por: Carm, Kristina Totland, et al.
Publicado: (2019)

A robust internal control for high-precision DNA methylation analyses by droplet digital PCR
por: Pharo, Heidi D., et al.
Publicado: (2018)

Molecular Characteristics of Malignant Ovarian Germ Cell Tumors and Comparison With Testicular Counterparts: Implications for Pathogenesis
por: Kraggerud, Sigrid Marie, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pdnesr6f2t1akaeo2reivt57f5